CENTERBOOK PARTNERS LP Halozyme Therapeutics, Inc. Transaction History

CENTERBOOK PARTNERS LP portfolio value:

$788,000
portfolio value

CENTERBOOK PARTNERS LP quarter portfolio value change:

-10.14%
quarter

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +97.57% 9.84K shares 344K $39.54 19.93K
Q2 2022 share Decrease -49.85% -10.02K shares -358K $44 10.08K
Q1 2022 share Increase +56.82% 7.28K shares 286K $39.88 20.11K
Q4 2021 share Increase 0.00% 12.82K shares 516K $40.32 12.82K